Stensen duct dilation: Case series of minimally invasive treatment.
Journal
Oral surgery, oral medicine, oral pathology and oral radiology
ISSN: 2212-4411
Titre abrégé: Oral Surg Oral Med Oral Pathol Oral Radiol
Pays: United States
ID NLM: 101576782
Informations de publication
Date de publication:
Jun 2019
Jun 2019
Historique:
received:
03
11
2018
revised:
12
01
2019
accepted:
16
01
2019
pubmed:
18
3
2019
medline:
16
1
2020
entrez:
18
3
2019
Statut:
ppublish
Résumé
Stensen's duct dilation is a rare condition characterized by a global or partial idiopathic dilation of the Stensen duct. Affected individuals usually show either aesthetically compromised features, such as a tubular-shaped swelling in the cheek, or with mildly painful inflammatory episodes. Three women between ages 61 and 67 years were diagnosed with Stensen duct dilation after sialo-magnetic resonance imaging (MRI). They were treated with botulinum toxin A (BTX-A). Our preliminary results suggest that BTX-A was efficient as a suspensive treatment. BTX-A should remain a first-line treatment of the early silent symptoms of Stensen duct dilation, such as swelling and aesthetic issues. The use of BTX-A avoids more serious procedures and further complications.
Identifiants
pubmed: 30878397
pii: S2212-4403(19)30106-3
doi: 10.1016/j.oooo.2019.01.078
pii:
doi:
Substances chimiques
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e114-e117Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.